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A B S T R A C T
Increasing evidence shows that latent infections and inflammation is associated with cognitive and behavioral
changes in humans. This case-control study investigates the association between Herpes Simplex Virus Type 1
(HSV-1) infection and C-reactive Protein (CRP) levels, and psychiatric disorders and suicidal behavior. Public
health register data from 81,912 participants in the Danish Blood Donor Study, were reviewed to identify in-
dividuals registered with an ICD-10 code of any psychiatric diagnosis, or who had attempted or committed
suicide. We found 1,504 psychiatric cases and 353 suicidal cases; for all cases, controls were frequency-matched
by age and sex, resulting in 5,336 participants. Plasma samples were analyzed for IgG-class antibodies against
HSV-1 and CRP. HSV-1 infection was associated with suicidal behavior (odds-ratio, 1.40; 95% confidence in-
terval [CI] 1.11–1.77). Accounting for temporality, HSV-1 infection was associated with having first psychiatric
disorder after the date of blood collection (incidence rate ration, 1.44; 95% CI, 1.05–1.95). No association
between CRP and psychiatric disorders or suicidal behavior was found. The finding that HSV-1 was associated
with suicidal behavior and first psychiatric disorder indicates that infection may play a role in the etiology and
pathogenesis of suicidal behavior and development of psychiatric disorders.
1. Introduction
Herpes Simplex Virus Type 1 (HSV-1), long considered largely in-
nocuous, is now suspected of harmful effects on human cognition and
behavior, even in individuals without clinical apparent encephalitis
(Becker, 1995; Dickerson et al., 2012; Schretlen et al., 2010; Yolken
et al., 2011).
HSV-1 is neurotropic and predominantly replicates in the frontal
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and temporal regions of the brain, where it potentially could lead to
cognitive impairments and memory alterations similar to those ob-
served in individuals with schizophrenia (Pramod et al., 2013; Prasad
et al., 2012). Latent neurotropic pathogens could contribute to cogni-
tive impairments and behavioral changes (Dickerson et al., 2017;
Duarte et al., 2019; Gale et al., 2016; Köhler-Forsberg et al., 2018;
Pramod et al., 2013; Simanek et al., 2017).
Herpes viruses establish lifelong latent infections and may, during
periods of reactivation, repeatedly induce an inflammatory response
(Glaser and Kiecolt-Glaser, 1994). It is not known to what extent, or
under which circumstances, inflammation, triggers psychiatric disease
onset. Age, stress, co-existent infections, and genetic and environmental
determinants of the immune response are potential reactivating factors
(Daheshia et al., 1998; Jones, 2003; Taylor et al., 2002; Xiao et al.,
2018). Psychiatric disease onset could be triggered by a chronic ele-
vated inflammatory response or one or more severe inflammatory
outbreaks throughout life. Reactivation of latent HSV-1 infection can
lead to somatic symptoms (cold sores) months or years after the pri-
mary infection. We hypothesize that latent HSV-1 infections also pro-
duce inflammatory responses that influence brain tissue and potentially
contribute to psychiatric disorders or suicidal behavior years or decades
after the primary infection.
Elevated levels of the inflammatory biomarker C-reactive protein
(CRP) is associated with psychiatric disorders (Wysokiński et al., 2015)
including schizophrenia (Dickerson et al., 2007a), bipolar disorder
(Dickerson et al., 2007b), depression (Ford and Erlinger, 2004), cog-
nitive impairment (Yaffe et al., 2003), and suicide (Park and Kim,
2017). The effects of CRP may be additive with genetic risk factors for
psychiatric disorders (Nimgaonkar et al., 2018). There is an additive
effect of elevated levels of antibodies to HSV-1 and CRP on cognitive
functioning in individuals with schizophrenia (Dickerson et al., 2012).
Furthermore, HSV-1 infection and inflammation (the latter assessed by
CRP levels) may both play a role in the etiology and pathogenesis of
psychiatric disorders and suicidal behavior (Nelson and Demmler,
1997).
Even though a possible link between common infectious pathogens
and inflammation, and the pathogenesis of psychiatric disorders and
self-violence has been described, it remains challenging to firmly es-
tablish these associations. It needs to be elucidated whether these as-
sociations reflect causality, and underlying mechanisms need to be
defined.
In the current study, we investigated the association between anti-
bodies to HSV-1 and CRP levels in relation to psychiatric and suicidal
outcomes in a large cohort of Danish blood donors. To provide in-
dicators regarding causality, we accounted for temporality, with the
exposure preceding the outcome of interest.
2. Methods and materials
2.1. Study population and overall design
The overall study design has been described previously (Sølvsten
Burgdorf et al., 2019). The Danish Blood Donor Study (DBDS) is an
ongoing national large-scale prospective cohort of voluntary Danish
blood donors recruited from blood donation centers across Denmark
since 2010 (Burgdorf et al., 2017, 2016; Pedersen et al., 2012). We
carried out a large-scale case-control study and a case-control study
nested in the DBDS to account for temporality, i.e., the exposure should
precede the outcome of interest. National registers for 81,912 in-
dividuals were reviewed to identify all cases registered with a psy-
chiatric diagnosis (1971–2013), had attempted or committed suicide
(1977–2011) or had been in a traffic accident (2008–2012). Cases with
a traffic accident were used in a previous study of toxoplasmosis
(Burgdorf et al., 2019). All cases were frequency matched by sex and
age with suitable controls, resulting in 12,500 cases and controls.
Plasma samples for cases and controls were randomized into three
batches and transferred to the Stanley Neurovirology Laboratory for
analysis. Information on HSV-1 and CRP levels was available for two of
the three batches, enabling us to study the effect of these on 1,504
psychiatric cases and 353 suicidal behavior cases, and their controls, in
total 5,336 individuals.
At recruitment, oral and written informed consent was obtained
from all participants and the study was carried out in accordance with
the latest version of the Declaration of Helsinki. The Danish Data
Protection Agency (2007-58-0015) and the Scientific Ethical
Committee of the Central Denmark Region (M-20090237) approved the
study.
2.2. Psychiatric diagnoses
The Danish Psychiatric Central Research Register (Mors et al., 2011)
is a nationwide register with person-specific information on all admis-
sions to Danish psychiatric inpatient facilities since 1969 and outpatient
facilities since 1995. Psychiatric diagnoses are coded according to the
International Classification of Diseases (ICD) - 8th Revision (WHO,
1965) between 1969 and 1993, inclusive; and 10th Revision (WHO,
1994) since 1994. Diagnosis of any psychiatric disorder (ICD-10: F00-
F99 and eq. ICD-8) and subgroups including schizophrenia and related
disorders (ICD-10: F20-F29 and eq. ICD-8 (Pedersen et al., 2014)),
mood disorders (ICD10: F30-F39 and eq. ICD8) and neurotic, stress-
related, and somatoform disorders (ICD-10: F40-F48 and eq. ICD-8)
before 2014 was obtained. Information on parental history of any
psychiatric diagnosis was obtained.
2.3. Attempting and committing suicide
Deliberate self-violence, such as attempting or committing suicide,
was defined in agreement with the criteria set by the Danish National
Patient Register (1977–2012), the Psychiatric Central Research Register
(1969–2013) and the Danish Registers of Causes of Death (1970–2011),
previously used in Danish register studies (Nordentoft, 2011). Only
episodes registered after the age of 15 years were considered. Diagnoses
are based on the ICD-8th Revision between 1977–1993 and ICD-10th
Revision from 1994 onward.
2.4. Immunological assays
Plasma samples from cases and controls were analyzed at the
Stanley Neurovirology Laboratory for specific enzyme-based im-
munoassays for immunoglobulin (IgG) class antibodies against HSV-1
and CRP, previously described (Dickerson et al., 2003). The raw IgG
antibodies titer values were standardized across plates and the dis-
tribution of the standardized z-score was fitted with two normal dis-
tributions to determine the cut-off value for each batch and for each
outcome of interest (Supplemental Figure S1 and S2). The cut-off was
set to match the area under the tails in the two normal distributions,
and a value above this cut-off was considered positive (or elevated).
2.5. Statistical methods
The associations between HSV-1 seropositivity or elevated CRP le-
vels and the risk of psychiatric disorders or suicidal behavior were
analyzed with a conditional logistic regression model on 5,336 in-
dividuals (1,504 psychiatric cases, 353 suicidal cases and 3,479 con-
trols). By design, we controlled for sex, age at time of blood collection
and adjusted for smoking and parental history of psychiatric disorder
before time of blood collection as previously described (Pedersen et al.,
2011). Additionally, we conducted an analysis where HSV-1 and CRP
were mutually adjusted.
Odds ratios (ORs) and 95% likelihood ratio confidence intervals
(95% CIs) were calculated, and a two-sided P-value of less than 0.05
was considered statistically significant. Statistical analyses were
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performed using the PHREG procedure in SAS 9.3 (SAS Institute, Cary,
North Carolina). Batch-specific estimates were calculated
(Supplemental Figure S3 and S4).
The nested case–control study was conducted to account for tem-
porality; i.e., the exposure should precede the outcome of interest to
fulfill Hill’s causation criteria (Hill, 1965; Rothman et al., 2008). For
each outcome of interest, only individuals with disease onset after the
date of blood sampling were included. Conditional logistic regression
for these cases and their time-, age-, and sex-matched controls were
conducted. This method provides estimates that are informative about
the risk of developing the outcomes of interest after exposure to HSV-1
or CRP levels; i.e., incidence-rate ratios (IRRs) (Pearce, 1993;
Vandenbroucke and Pearce, 2012).
3. Results
A total of 5336 cases and controls were enrolled in this study. The
distribution of cases and controls (non-exclusive) are shown in Table 1.
Overall, 1504 individuals (853 women) were registered with a psy-
chiatric disorder and 353 individuals (193 women) had attempted or
committed suicide. The average age at blood donation was 37.6 years
(Supplemental Figure S5) and 50.9% had serological evidence of HSV-
1 infection and 46.5% had elevated CRP levels.
Attempting or committing suicide was associated with HSV-1 (OR,
1.40; 95%CI, 1.11–1.77) (Table 1). Considering only the 10 cases who
for the first time attempted or committed suicide after the date of blood
collection, no association between HSV-1 and subsequent suicide or
suicide attempts was observed (IRR, 0.78; 95%CI, 0.21–2.98).
Accounting for temporality (considering only individuals diagnosed
after the date of blood collection) HSV-1 was associated with devel-
oping any psychiatric disorder (IRR, 1.45; 95% CI, 1.06–2.00)
(Table 1).
No associations between CRP levels and psychiatric disorders or
suicidal behavior were found (Table 1).
4. Discussion
This large-scale seroepidemiological case–control study is the first
to show an association between HSV-1 infection and the risk of at-
tempting or committing suicide in an otherwise healthy population.
This finding indicates that HSV-1 infection may be a contributing factor
for suicidal behavior. Moreover, we found that HSV-1 infection could
be a contributing causal factor for development of any psychiatric
disorder, as we show that infection with HSV-1 occurred prior first
registered psychiatric diagnosis. Our results are in agreement with and
supports the findings that primary HSV-1 infection, in some individuals,
may decade after lead to neural damage that promote or contribute to
neurodegenerative disorders (Duarte et al., 2019).
The consequences of latent infection may significantly differ de-
pending on its timing, the stages of brain development; and the site of
entrance, localization, and distribution in the brain. These factors may
result in varying degrees of lifelong changes in behavior and cognition
(Yolken and Torrey, 2008). Antibody titers reflect pathogen infection,
but they provide little information about the timing, localization, dis-
tribution or duration of the infection. HSV-1 antibody titers accurately
reflect the presence of central nervous system HSV-1 infection in post-
mortem studies of humans and rodents (Hill et al., 2008). Because of
the repeated cycles of reactivation, viral titers generally remain ele-
vated throughout life. In individuals who do not experience repeated
cycles of reactivations, antibody titers tend to decline over time. Anti-
body titers reflect exposure as well as host-related factors; such as ge-
netic variations affecting immune responses and may in some in-
dividuals lead to lower antibody titers. Latent HSV-1 infection or
genetic variations affecting the immune responses could result in a
reduced association between HSV-1 infection and cognitive dysfunction
(Prasad et al., 2012). Ta
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Lifelong latent infections may, during repeated cycles of latency and
reactivation, over time lead to a decrease in cortical gray matter with
consequent cognitive impairment, thus participating in the pathological
processes of severe psychiatric disorders such as schizophrenia and
bipolar disorder (Prasad et al., 2011, 2007). A causal relationship be-
tween serological evidence of HSV-1 infection and memory deficits has
only been well studied in individuals with schizophrenia (Dickerson
et al., 2012, 2004; Prasad et al., 2012; Schretlen et al., 2010; Shirts
et al., 2008; Yolken et al., 2011). HSV-1 infection and elevated CRP
levels are associated with the severity of cognitive impairment in
schizophrenia. In addition, an additive effect of inflammation (assessed
by circulating CRP level) and history of HSV-1 infection on immediate
memory is found. These findings indicate that infection and in-
flammation may play a major role in the cognitive deficits associated
with schizophrenia (Dickerson et al., 2012). In this study, we found that
HSV-1 infection was associated with having any psychiatric disorder,
but only in individuals registered with first psychiatric disorder after
the date of blood collection and – the infection occurred prior first re-
gistered psychiatric diagnosis. As a marker of general inflammation
CPR levels was analyzed, but no association between CRP levels and
psychiatric disorders or suicidal behavior were found. We cannot rule
out that reactivation of latent HSV-1 infection may induce a locale
neuroinflammatory response in the brain that potential could invoke
severe cognitive dysfunctionalities associated with psychiatric disorders
or suicidal behavior.
There may exist a window of opportunity for treating HSV-1 in-
fections prior to the time they lead to irreversible damage to key cor-
tical networks leading to development of cognitive deficits. Irreversible
damage to key cortical networks could not be ameliorated by antiviral
therapies (Breier et al., 2018). Therefore, treating individuals before
they develop irreversible cortical network damage may be a more ef-
fective treatment than treating individuals who already developed ir-
reversible damage leading to psychiatric disorders (Breier et al., 2018;
Prasad et al., 2013).
The strength of our study is that it is based on a large, nationwide
population tested for HSV-1 and CRP levels, and that we were able to
account for temporality (i.e., whether the pathogen exposure precedes
the outcome), smoking and parental history of psychiatric disorders. A
limitation of this study is that we could not determine the etiological
relationship between HSV-1 infection and CRP levels; nor directly prove
a causal relationship between HSV-1 or CRP and suicidal tendency. We
assessed past HSV-1 exposure and current CRP status; this may be
problematic, as the timeframes differ.
Moreover, only IgG levels of HSV-1, indicator of lifelong HSV-1
infection, was analyzed. IgM levels of HSV-1, indicator of primary in-
fection or reactivation of the virus, was not analyzed. We were not able
to control for socioeconomic factors, which may influence probability
of pathogen infection, psychiatric disorders or suicidal behavior.
Moreover, behavioral changes due to psychiatric disorders may lead to
higher risk of contracting infectious diseases, including HSV-1. In ad-
dition, we were only able to control for current smoking status but not
factors like diet and allergies that might also influence CRP levels. We
cannot rule out the possibility that these factors account for part or all
of the observed effect. The generalizability to other settings may be
limited, since the study population comprises of voluntary blood donors
who are healthier than the general population; older blood donors in
particular represent a highly selected group of individuals (the healthy
donor effect) (Rigas et al., 2017). These factors can also influence the
probability of pathogen infection, psychiatric disorders or suicidal be-
havior.
For future studies, our cohort holds some unique advantages for
studying development of psychiatric disorders and suicidal behavior.
What is exceptional is that we have a large numbers of consecutive
samples per individual, to explore change in inflammatory markers in
infected and non-infected individual prior to disease onset or suicidal
behavior.
In conclusion, this largest to date seroepidemiology study is the first
to show that HSV-1 infection may be a risk factor for self-directed
violence in the form of attempting or committing suicide, in an other-
wise healthy population. Interesting, we also showed that HSV-1 in-
fection occurred prior first registered psychiatric diagnosis. Targeting
HSV-1 infection may potential provide novel diagnostic and therapeutic
approaches. Treating HSV-1 infection prior to the time they lead to
suicidal behavior or psychiatric disorders may be more effective than
treating individuals who already have developed suicidal behavior or
psychiatric disorders, thus supporting a causal relationship.
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